genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Latest
All
More
Cancer
Roche-Poseida Lead Allogeneic CAR-T Advances after Showing Promise in Multiple Myeloma
Genome Editing
Prime Medicine Inks Up-to-$3.5B Collaboration with BMS, Narrows Pipeline
OMICs
StockWatch: Turnaround Lifts GeneDx Stock 3,600%, with Profitability Near
Drug Discovery
Pfizer Withdraws SCD Drug Oxbryta after EMA Discloses 16 Deaths in Trials
Artificial Intelligence
Nvidia Launches AI Reference Workflow for Drug Discoverers
Artificial Intelligence
Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration
Drug Discovery
StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat
Industry News
Double Impact: Interest Rates and Prospects For Biotech Growth
Drug Discovery
StockWatch: Moderna’s $1.1B R&D Cut, Profitability Delay Jolt Investors
Drug Discovery
StockWatch: Athira Pays Price as Alzheimer’s Candidate Fails Trial
Drug Discovery
$600M+ Credit Firm Targets Life-Sci Companies in Later Stages
Artificial Intelligence
Recursion’s Ambitions: Developing 100+ Candidates, Joining with Exscientia
Drug Discovery
HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration
Drug Discovery
Avak Kahvejian, PhD, Recounts His Journey from Sequencing Pioneer to Flagship General Partner on “Close to the Edge”
Artificial Intelligence
Recursion’s CEO Discusses Pipeline Growth, Approach to AI and ML
OMICs
Illumina and the State of the Genomics Market
Drug Discovery
StockWatch: Neurocrine Tumbles as Schizophrenia Data Disappoints
Cancer
Hold and Kill: Halda Raises $126M toward Precision Cancer Treatments
OMICs
StockWatch: Analysts Positive on Illumina’s New Strategy
Drug Discovery
StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk
Artificial Intelligence
Recursion to Acquire Exscientia, Combining AI Drug Pioneers
Artificial Intelligence
With $10M from Gates Foundation, Schrödinger Takes Aim at Toxicity Risk
Artificial Intelligence
Giving Structure to Language: Profluent’s AI Models Move toward Precise and Steerable Protein Design
Drug Discovery
StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data
Drug Discovery
RNA Editing Therapy Developer Closes $60M Series A Financing
Drug Discovery
GSK, Flagship Launch Up-to-$7B+ Development Partnership
Drug Discovery
Lecanemab Approval for Early Alzheimer’s Disease Hits Roadblock in Europe
Drug Discovery
StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares
Artificial Intelligence
Flagship Pioneering Unveils Abiologics with Focus on “Supranatural” Biologics
Summits
The State of Biotech 2024
Load more
Scroll Up